Načítá se...
Sodium–glucose cotransporter 2 (SGLT-2) inhibitors: a new antidiabetic drug class
Diabetes mellitus is a chronic, complex and multifactorial disease associated characteristically with hyperglycemia. One of the most recently approved antidiabetic drug classes for clinical use are sodium–glucose cotransporter type 2 (SGLT-2) inhibitors. SGLT-2 is a protein expressed in the kidneys,...
Uloženo v:
| Vydáno v: | Medchemcomm |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Royal Society of Chemistry
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6096352/ https://ncbi.nlm.nih.gov/pubmed/30151080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c8md00183a |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|